Cancer Center Support Grant Site Review Date
description
Transcript of Cancer Center Support Grant Site Review Date
![Page 1: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/1.jpg)
Cancer Center Support Grant Site ReviewDate
Cancer Center Support Grant Site ReviewDate
Signals, Pathways and Targets
Program Leaders: John Lowengrub, Ph.D.
Marian L. Waterman, Ph.D.2011 Chao Family Cancer Center Retreat
Palm Springs
![Page 2: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/2.jpg)
Rationale
• Cancer is a complex adaptive system with dynamic regulatory pathways (Dev Biol, Cell Biol, Biochem)
• Modeling dynamic interactions is critical for understanding progression and response to treatment (Systems Biol)
• The SPT program reflects this multi-disciplinary approach to cancer
![Page 3: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/3.jpg)
Systems, Pathways and Target Program: 56 members
![Page 4: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/4.jpg)
The SPT ProgramCancer Relevant SPT Publications, 1/2011 – 9/2011
![Page 5: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/5.jpg)
Total for Program SPT(Cancer Projects)
NCI
Other NIH
ACS
NSF
Other Peer Reviewed
Industry Non-Peer Reviewed
Other Non-Peer Reviewed
$17,134,815 Total Annual Direct Costs (peer reviewed)
$2,695,977 (NCI)
Signals, Pathways and Targets: Program Metrics
![Page 6: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/6.jpg)
![Page 7: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/7.jpg)
Systems, Pathways and Targets Program ThemesSystems Organ Pathway Target
Baldi (Blumberg) Anderson (Bardwell)
Bardwell Calof Arora (Edinger)
(Calof) Donovan Blumberg (Fruman)
Frank (Hoang) Casali Kaiser
(Komarova) (Krowleski) Chan Komarova
Lander (Lander) Cho (Steele)
Nie (Lee, E) Dai (Thompson)
Thornton Limoli Edinger (Walsh)
Wan (Lowengrub) Fan (Waterman)
(Wodarz) (Nie) Fruman Wodarz
(Zlotnik) Schilling Hoang (Zlotnik)
Steele Huang, L
(Wan) Huang, T
(Zhou) Kaiser
Krolewski
(Lander)
Lee, E
Levin
Lilly
(Nie)
Sandmeyer
Sassone-Corsi
(Schilling)
Thompson
(Want)
Walsh
Warrior
Waterman
Yokomori
Zlotnik
![Page 8: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/8.jpg)
Program Co-Leader: John Lowengrub
•Angiogenesis•Macrophages•Fibroblasts•Immune cells
NIH GO Grant. PIs: Lander, Lowengrub
![Page 9: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/9.jpg)
13 National Centers for Systems Biology (NIH P50)PI: Lander (SPT)Other key personnel: SPT: Calof, Bardwell, Nie, WanOIB: Gratton
http://www.systemscenters.org/
Renewal (2011):Theme B (Calof): Control of Growth
and MorphogenesisSPT: Edwards, Lander, Lowengrub,
Nie, Waterman
Intestinal organoids
![Page 10: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/10.jpg)
New research initiative•Cellular cross-talk in the human colon cancer microenvironmentNIH/PPG: Expected submission: May 2012PI: Hughes (ABT); Project leaders: Waterman (SPT), Hughes (ABT), George (ABT), Lowengrub (SPT); Core directors: Hughes, Edwards (SPT), Hui
Waterman Hughes
George Lowengrub
![Page 11: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/11.jpg)
Komarova Wodarz
Systems Modeling
![Page 12: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/12.jpg)
Bench to Bedside: Krolewski, Fruehauf, Lilly, Dash
Prostate Disease Oriented Team (DOT) Clinical Trials Open for Accrual: 11Trials developed directly from DOT activities: 3 (UCI-10-11; UCI-10-41; UCI-
11-02)
![Page 13: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/13.jpg)
cMetNeuropilin
Dr. Bang HoangWnt Signaling in Sarcomas
![Page 14: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/14.jpg)
Wnt Signaling and Metastasisin OsteosarcomaWIF-1, Frzb
Druggable Wnt Target Genesc-METNeuropilin
2011 Kappa Delta Ann Doher Vaughn Award
Career Development Award: 2011 - 2014
NIH K08 CA11600
Dr. Bang HoangWnt Signaling in Sarcomas
![Page 15: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/15.jpg)
PP242INK128
Bench to Bedside: Dr. David Fruman
![Page 16: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/16.jpg)
Dr. David Fruman
Next-Gen mTOR inhibitors
![Page 17: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/17.jpg)
A New Target: Dr. Aimee Edinger
![Page 18: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/18.jpg)
PI: Aimee Edinger (SPT)Collaborators: David Fruman (SPT), Michael Lilly (SPT)
Oct. 2011
![Page 19: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/19.jpg)
Proteomic ToolsScientific Highlights
Dr. Lan Huang, PhD: Mass Spectrometry1. New protein tagging strategies: tandem tags, in vivo biotinylation
2. Novel cross-linking chemistries: click-chemistry, novel spacers
3. Rapid Protein Complex IsolationProteasome network – collaboration with Dr. Peter Kaiser
Global Ubiquitination, Neddylation Network – collaboration with Dr. Peter KaiserRNA/Protein complexes (MS2-BioTRAP) – NCI IMAT R21CA133275
Tsai BP, Wang X, Huang L, Waterman ML.
2011. Mol Cell Proteomics.
“Quantitative Profiling of In Vivo-assembled RNA-Protein Complexes Using a Novel Integrated Proteomic Approach”
planned: NCI IMAT R33 Multi-PI RO1
![Page 20: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/20.jpg)
CSB
SPT Discoveries:Moving Targets Closer to the Bedside
![Page 21: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/21.jpg)
p53 Rescue A Functional Census of p53 Cancer and Suppressor MutantsDr. Peter Kaiser (SPT; PI) and Dr. Rick Lathrop (CSB; contact PI)
NCI R012010
Currently: in silico screen of >2,000,000 small molecules small molecule synthesis and test in cells
Scientific Highlights:
![Page 22: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/22.jpg)
BiologyKaiser Lab, PI (SPT)Biological Chemistry
ChemistryChamberlin Lab (CSB)Pharmaceutical Sciences
Machine LearningLathrop Group, PI (CSB)Computer Science
Molecular BiologyHatfield Lab Computational BiologyResearch Laboratory
Molecular Dynamics
Amaro Group Pharmaceutical Sciences
Mouse GeneticsLee Lab (ABT)Biological Chemistry
Structural BiologyCocco Lab (NMR) (CSB)Luecke Lab (X-ray) (CSB)Molecular Biology and Biochemistry
Cancer Center - Value AddedNIH/NCI T32 #CA113265GHTF CoreCFCCC Seed grants
The p53 TeamScientific Highlights
![Page 23: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/23.jpg)
The SPT ProgramChallenges• Size• Diversity of Discipline• Geographic Location (UCIMC, Main Campus, SOM)
Meeting the Challenges• Communication• Monitoring• Meetings• Goal: Linking Basic and Clinical groups
Disease Oriented TeamsJohn Krolewski (SPT): Prostate CancerRob Edwards (SPT)/Jason Zell (PPS): Colon
Cancer
![Page 24: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/24.jpg)
![Page 25: Cancer Center Support Grant Site Review Date](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681631b550346895dd3935b/html5/thumbnails/25.jpg)
Systems, Pathways and Targets ProgramCo-Leaders: Dr. John Lowengrub, Dr. Marian Waterman